Tecon Biology Co.,ltd (stock code 002100) is state-owned integrated industrialized company who is providing veterinary production, feed, protein oil, pig cultivation, food processing and delivering. It has 28 subordinate companies, staffs over 5000, registered capital 0.96 billion CHY, fixed assets 1.89 billion CHY. up to year 2016, operation receipt realize 4.44 billion CHY with profit 0.43 billion CHY.
Tecon Biology Co.,ltd is national key leading enterprises of agricultural industrialization. Technology center of the company belongs to national technology center. It is awarded “high new technology industrialization achievement during 10 ten years ” by National Development and Reform Commission, “leading feed enterprise executing social responsibility ”by PRC feed industry association. Tecon Biology Co., ltd became listed company on 26 December 2016 at Shenzhen Stock Exchange.
Tecon ’s subordinated Pharmacy Undertakings Department’s predecessor body, Xinjiang Veterinary Pharmaceutical Factory is one of the earliest 28 manufacturers for producing veterinary biological products appointed by the Ministry of Agriculture. Tecon Pharmacy Undertakings Department has step by step built and basically formed three major production bases, i.e. Urumqi Economic and Technological Development Zone Foot and Mouth Disease Vaccine, Urumqi High-tech District North Zone Swine Series Vaccine and Jilin Meihekou City Guanjie Biological AIV Suspension Culture Vaccine. The peste des petits ruminants living vaccine, foot and mouth disease living vaccine, foot and mouth disease synthetic peptide vaccine, government-procured classical swine fever living vaccine (cell line origin) and porcine reproductive and respiratory syndrome living vaccine are sold throughout the country. Sale amount of year 2017 is 0.75 billion CHY, among which FMD vaccine is 0.4 billion.
Occupancy of PPR living vaccine (strain Nigerian 75/1) produced by Tecon Biology Co., Ltd ranked first in Chinese veterinary market. The vaccine is with highly quality as internal controlling standard for the vaccine exceeds national controlling standard. The vaccine has been widely used for 5 consecutive years over almost all provinces and achieved favorable comments from clients on product quality, service and reputation.
